Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)

Diabetic nephropathy (DN) is associated with inflammation. Platycodin D (PD) demonstrates anti-inflammatory activity. However, whether PD affects DN remains to be explored. Here, we aimed to discuss the role of PD in DN and its underlying mechanisms. High glucose (HG)-induced HK-2 cells were treated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioengineered 2022-03, Vol.13 (3), p.6627-6637
Hauptverfasser: Huang, Jinzhong, Chen, Gangyi, Wang, Jilei, Liu, Shibin, Su, Jing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6637
container_issue 3
container_start_page 6627
container_title Bioengineered
container_volume 13
creator Huang, Jinzhong
Chen, Gangyi
Wang, Jilei
Liu, Shibin
Su, Jing
description Diabetic nephropathy (DN) is associated with inflammation. Platycodin D (PD) demonstrates anti-inflammatory activity. However, whether PD affects DN remains to be explored. Here, we aimed to discuss the role of PD in DN and its underlying mechanisms. High glucose (HG)-induced HK-2 cells were treated with PD, and cell viability was assessed using the Thiazolyl Blue Tetrazolium Bromide (MTT) assay. Ferroptosis-related factors such as lactate dehydrogenase (LDH) activity, lipid reactive oxygen species (ROS), iron (Fe 2+ ) level, GSH level, and malondialdehyde (MDA) level were evaluated. Cell death was evaluated using the TUNEL assay. GPX4 expression was evaluated using Quantitative Real-time PCR (qRT-PCR) and Western blotting analysis. The results indicated that HG increased LDH activity, lipid ROS production, Fe 2+ levels, and MDA levels and decreased GSH levels, suggesting that the HG condition induced ferroptosis. PD treatment inhibited ferroptosis in HG-induced cells, downregulated ACSL4 and TFR1 expression, and upregulated FTH-1 and SLC7A11 expression. PD reversed the effects of HG condition on cell death. Moreover, GPX4 expression was downregulated in HG-stimulated cells. Furthermore, we substantiated that PD suppressed ferroptosis by modulating GPX4 expression. In conclusion, PD inhibited ferroptosis in HG-induced HK-2 cells by upregulating GPX4 expression, suggesting that PD may be an effective drug for the clinical treatment of DN.
doi_str_mv 10.1080/21655979.2022.2045834
format Article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_proquest_miscellaneous_2634849851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2634849851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-6bc0bc8290e8db9ce1f86d25d9e47811a95b5649c943204b2ad048ae47bda1bc3</originalsourceid><addsrcrecordid>eNp9UcFu1DAQtRCIVm0_AeRjOaTYjp3YFwQqpUWtRA8gcbMce7IxSuLFdmj37-vVbldw4eLxzLz3ZkYPoTeUXFAiyXtGGyFUqy4YYaw8XMiav0DH23ollGxfHv6tOkJnKf0ihFBSc9HK1-ioFow1kqljNN2PJm9scH7Gn3GE1VJySHjwqwGvxsWGBJWf3WLB4R5iDOsckk849PjmtmLYwjgmnIcYlh0jmzz4MANeQwyP3pkEmOPz6_uf_N0petWbMcHZPp6gH1-uvl_eVHffrr9efrqrLG9krprOks6W_QhI1ykLtJeNY8Ip4K2k1CjRiYYrq3hdju-YcYRLU5qdM7Sz9Qn6sNNdL90EzsKcoxn1OvrJxI0Oxut_O7Mf9Cr80VK1tZSqCJzvBWL4vUDKevJpe6qZISxJs6bmkispaIGKHdTGkFKE_jCGEr11Sz-7pbdu6b1bhff27x0PrGdvCuDjDuDnPsTJPIQ4Op3NZgyxj2a2Pun6_zOeANB0pZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2634849851</pqid></control><display><type>article</type><title>Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)</title><source>Taylor &amp; Francis Open Access</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Huang, Jinzhong ; Chen, Gangyi ; Wang, Jilei ; Liu, Shibin ; Su, Jing</creator><creatorcontrib>Huang, Jinzhong ; Chen, Gangyi ; Wang, Jilei ; Liu, Shibin ; Su, Jing</creatorcontrib><description>Diabetic nephropathy (DN) is associated with inflammation. Platycodin D (PD) demonstrates anti-inflammatory activity. However, whether PD affects DN remains to be explored. Here, we aimed to discuss the role of PD in DN and its underlying mechanisms. High glucose (HG)-induced HK-2 cells were treated with PD, and cell viability was assessed using the Thiazolyl Blue Tetrazolium Bromide (MTT) assay. Ferroptosis-related factors such as lactate dehydrogenase (LDH) activity, lipid reactive oxygen species (ROS), iron (Fe 2+ ) level, GSH level, and malondialdehyde (MDA) level were evaluated. Cell death was evaluated using the TUNEL assay. GPX4 expression was evaluated using Quantitative Real-time PCR (qRT-PCR) and Western blotting analysis. The results indicated that HG increased LDH activity, lipid ROS production, Fe 2+ levels, and MDA levels and decreased GSH levels, suggesting that the HG condition induced ferroptosis. PD treatment inhibited ferroptosis in HG-induced cells, downregulated ACSL4 and TFR1 expression, and upregulated FTH-1 and SLC7A11 expression. PD reversed the effects of HG condition on cell death. Moreover, GPX4 expression was downregulated in HG-stimulated cells. Furthermore, we substantiated that PD suppressed ferroptosis by modulating GPX4 expression. In conclusion, PD inhibited ferroptosis in HG-induced HK-2 cells by upregulating GPX4 expression, suggesting that PD may be an effective drug for the clinical treatment of DN.</description><identifier>ISSN: 2165-5979</identifier><identifier>EISSN: 2165-5987</identifier><identifier>DOI: 10.1080/21655979.2022.2045834</identifier><identifier>PMID: 35226829</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Cell Line ; Diabetic nephropathy ; ferroptosis ; Ferroptosis - drug effects ; Glucose - metabolism ; GPX4 ; HK-2 cells ; Humans ; Phospholipid Hydroperoxide Glutathione Peroxidase - genetics ; Phospholipid Hydroperoxide Glutathione Peroxidase - metabolism ; platycodin D ; Saponins - pharmacology ; Triterpenes - pharmacology</subject><ispartof>Bioengineered, 2022-03, Vol.13 (3), p.6627-6637</ispartof><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2022</rights><rights>2022 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-6bc0bc8290e8db9ce1f86d25d9e47811a95b5649c943204b2ad048ae47bda1bc3</citedby><cites>FETCH-LOGICAL-c468t-6bc0bc8290e8db9ce1f86d25d9e47811a95b5649c943204b2ad048ae47bda1bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973889/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973889/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35226829$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Jinzhong</creatorcontrib><creatorcontrib>Chen, Gangyi</creatorcontrib><creatorcontrib>Wang, Jilei</creatorcontrib><creatorcontrib>Liu, Shibin</creatorcontrib><creatorcontrib>Su, Jing</creatorcontrib><title>Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)</title><title>Bioengineered</title><addtitle>Bioengineered</addtitle><description>Diabetic nephropathy (DN) is associated with inflammation. Platycodin D (PD) demonstrates anti-inflammatory activity. However, whether PD affects DN remains to be explored. Here, we aimed to discuss the role of PD in DN and its underlying mechanisms. High glucose (HG)-induced HK-2 cells were treated with PD, and cell viability was assessed using the Thiazolyl Blue Tetrazolium Bromide (MTT) assay. Ferroptosis-related factors such as lactate dehydrogenase (LDH) activity, lipid reactive oxygen species (ROS), iron (Fe 2+ ) level, GSH level, and malondialdehyde (MDA) level were evaluated. Cell death was evaluated using the TUNEL assay. GPX4 expression was evaluated using Quantitative Real-time PCR (qRT-PCR) and Western blotting analysis. The results indicated that HG increased LDH activity, lipid ROS production, Fe 2+ levels, and MDA levels and decreased GSH levels, suggesting that the HG condition induced ferroptosis. PD treatment inhibited ferroptosis in HG-induced cells, downregulated ACSL4 and TFR1 expression, and upregulated FTH-1 and SLC7A11 expression. PD reversed the effects of HG condition on cell death. Moreover, GPX4 expression was downregulated in HG-stimulated cells. Furthermore, we substantiated that PD suppressed ferroptosis by modulating GPX4 expression. In conclusion, PD inhibited ferroptosis in HG-induced HK-2 cells by upregulating GPX4 expression, suggesting that PD may be an effective drug for the clinical treatment of DN.</description><subject>Cell Line</subject><subject>Diabetic nephropathy</subject><subject>ferroptosis</subject><subject>Ferroptosis - drug effects</subject><subject>Glucose - metabolism</subject><subject>GPX4</subject><subject>HK-2 cells</subject><subject>Humans</subject><subject>Phospholipid Hydroperoxide Glutathione Peroxidase - genetics</subject><subject>Phospholipid Hydroperoxide Glutathione Peroxidase - metabolism</subject><subject>platycodin D</subject><subject>Saponins - pharmacology</subject><subject>Triterpenes - pharmacology</subject><issn>2165-5979</issn><issn>2165-5987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><recordid>eNp9UcFu1DAQtRCIVm0_AeRjOaTYjp3YFwQqpUWtRA8gcbMce7IxSuLFdmj37-vVbldw4eLxzLz3ZkYPoTeUXFAiyXtGGyFUqy4YYaw8XMiav0DH23ollGxfHv6tOkJnKf0ihFBSc9HK1-ioFow1kqljNN2PJm9scH7Gn3GE1VJySHjwqwGvxsWGBJWf3WLB4R5iDOsckk849PjmtmLYwjgmnIcYlh0jmzz4MANeQwyP3pkEmOPz6_uf_N0petWbMcHZPp6gH1-uvl_eVHffrr9efrqrLG9krprOks6W_QhI1ykLtJeNY8Ip4K2k1CjRiYYrq3hdju-YcYRLU5qdM7Sz9Qn6sNNdL90EzsKcoxn1OvrJxI0Oxut_O7Mf9Cr80VK1tZSqCJzvBWL4vUDKevJpe6qZISxJs6bmkispaIGKHdTGkFKE_jCGEr11Sz-7pbdu6b1bhff27x0PrGdvCuDjDuDnPsTJPIQ4Op3NZgyxj2a2Pun6_zOeANB0pZQ</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Huang, Jinzhong</creator><creator>Chen, Gangyi</creator><creator>Wang, Jilei</creator><creator>Liu, Shibin</creator><creator>Su, Jing</creator><general>Taylor &amp; Francis</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220301</creationdate><title>Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)</title><author>Huang, Jinzhong ; Chen, Gangyi ; Wang, Jilei ; Liu, Shibin ; Su, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-6bc0bc8290e8db9ce1f86d25d9e47811a95b5649c943204b2ad048ae47bda1bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cell Line</topic><topic>Diabetic nephropathy</topic><topic>ferroptosis</topic><topic>Ferroptosis - drug effects</topic><topic>Glucose - metabolism</topic><topic>GPX4</topic><topic>HK-2 cells</topic><topic>Humans</topic><topic>Phospholipid Hydroperoxide Glutathione Peroxidase - genetics</topic><topic>Phospholipid Hydroperoxide Glutathione Peroxidase - metabolism</topic><topic>platycodin D</topic><topic>Saponins - pharmacology</topic><topic>Triterpenes - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Jinzhong</creatorcontrib><creatorcontrib>Chen, Gangyi</creatorcontrib><creatorcontrib>Wang, Jilei</creatorcontrib><creatorcontrib>Liu, Shibin</creatorcontrib><creatorcontrib>Su, Jing</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioengineered</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Jinzhong</au><au>Chen, Gangyi</au><au>Wang, Jilei</au><au>Liu, Shibin</au><au>Su, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)</atitle><jtitle>Bioengineered</jtitle><addtitle>Bioengineered</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>13</volume><issue>3</issue><spage>6627</spage><epage>6637</epage><pages>6627-6637</pages><issn>2165-5979</issn><eissn>2165-5987</eissn><abstract>Diabetic nephropathy (DN) is associated with inflammation. Platycodin D (PD) demonstrates anti-inflammatory activity. However, whether PD affects DN remains to be explored. Here, we aimed to discuss the role of PD in DN and its underlying mechanisms. High glucose (HG)-induced HK-2 cells were treated with PD, and cell viability was assessed using the Thiazolyl Blue Tetrazolium Bromide (MTT) assay. Ferroptosis-related factors such as lactate dehydrogenase (LDH) activity, lipid reactive oxygen species (ROS), iron (Fe 2+ ) level, GSH level, and malondialdehyde (MDA) level were evaluated. Cell death was evaluated using the TUNEL assay. GPX4 expression was evaluated using Quantitative Real-time PCR (qRT-PCR) and Western blotting analysis. The results indicated that HG increased LDH activity, lipid ROS production, Fe 2+ levels, and MDA levels and decreased GSH levels, suggesting that the HG condition induced ferroptosis. PD treatment inhibited ferroptosis in HG-induced cells, downregulated ACSL4 and TFR1 expression, and upregulated FTH-1 and SLC7A11 expression. PD reversed the effects of HG condition on cell death. Moreover, GPX4 expression was downregulated in HG-stimulated cells. Furthermore, we substantiated that PD suppressed ferroptosis by modulating GPX4 expression. In conclusion, PD inhibited ferroptosis in HG-induced HK-2 cells by upregulating GPX4 expression, suggesting that PD may be an effective drug for the clinical treatment of DN.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>35226829</pmid><doi>10.1080/21655979.2022.2045834</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2165-5979
ispartof Bioengineered, 2022-03, Vol.13 (3), p.6627-6637
issn 2165-5979
2165-5987
language eng
recordid cdi_proquest_miscellaneous_2634849851
source Taylor & Francis Open Access; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Cell Line
Diabetic nephropathy
ferroptosis
Ferroptosis - drug effects
Glucose - metabolism
GPX4
HK-2 cells
Humans
Phospholipid Hydroperoxide Glutathione Peroxidase - genetics
Phospholipid Hydroperoxide Glutathione Peroxidase - metabolism
platycodin D
Saponins - pharmacology
Triterpenes - pharmacology
title Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T17%3A38%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Platycodin%20D%20regulates%20high%20glucose-induced%20ferroptosis%20of%20HK-2%20cells%20through%20glutathione%20peroxidase%204%20(GPX4)&rft.jtitle=Bioengineered&rft.au=Huang,%20Jinzhong&rft.date=2022-03-01&rft.volume=13&rft.issue=3&rft.spage=6627&rft.epage=6637&rft.pages=6627-6637&rft.issn=2165-5979&rft.eissn=2165-5987&rft_id=info:doi/10.1080/21655979.2022.2045834&rft_dat=%3Cproquest_infor%3E2634849851%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2634849851&rft_id=info:pmid/35226829&rfr_iscdi=true